RNA Binding of Ebola Virus VP30 Is Essential for Activating Viral Transcription.
The template for Ebola virus (EBOV) transcription and replication is the helical viral nucleocapsid composed of the viral negative-sense (-) RNA genome, which is complexed by the nucleoprotein (NP), VP35, polymerase L, VP24, and VP30. While viral replication is exerted by polymerase L and its cofactor VP35, EBOV mRNA synthesis is regulated by the viral nucleocapsid protein VP30, an essential EBOV-specific transcription factor. VP30 is a homohexameric phosphoprotein containing a nonconventional zinc finger. The transcriptional support activity of VP30 is strongly influenced by its phosphorylation state. We studied here how RNA binding contributed to VP30's function in transcriptional activation. Using a novel mobility shift assay and the 3'-terminal 154 nucleotides of the EBOV genome as a standard RNA substrate, we detected that RNA binding of VP30 was severely impaired by VP30 mutations that (i) destroy the protein's capability to form homohexamers, (ii) disrupt the integrity of its zinc finger domain, (iii) mimic its fully phosphorylated state, or (iv) alter the putative RNA binding region. RNA binding of the mutant VP30 proteins correlated strongly with their transcriptional support activity. Furthermore, we showed that the interaction between VP30 and the polymerase cofactor VP35 is RNA dependent, while formation of VP30 homohexamers and VP35 homotetramers is not. Our data indicate that RNA binding of VP30 is essential for its transcriptional support activity and stabilizes complexes of VP35/L polymerase with the (-) RNA template to favor productive transcriptional initiation in the presence of termination-active RNA secondary structures.



Ebola virus causes severe fevers with unusually high case fatality rates. The recent outbreak of Ebola virus in West Africa claimed more than 11,000 lives and threatened to destabilize a whole region because of its dramatic effects on the public health systems. It is currently not completely understood how Ebola virus manages to balance viral transcription and replication in the infected cells. This study shows that transcriptional support activity of the Ebola virus transcription factor VP30 is highly correlated with its ability to bind viral RNA. The interaction between VP30 and VP35, the Ebola virus polymerase cofactor, is dependent on the presence of RNA as well. Our data contribute to the understanding of the dynamic interplay between nucleocapsid proteins and the viral RNA template in order to promote viral RNA synthesis.
Institut für Virologie, Philipps-Universität Marburg, Marburg, Germany.
Nadine
N
Biedenkopf
Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marburg, Germany.
Julia
J
Schlereth
Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marburg, Germany.
Arnold
A
Grünweller
Institut für Virologie, Philipps-Universität Marburg, Marburg, Germany becker@staff.Uni-Marburg.de roland.hartmann@staff.uni-marburg.de.
Stephan
S
Becker
Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marburg, Germany becker@staff.Uni-Marburg.de roland.hartmann@staff.uni-marburg.de.
Roland K
RK
Hartmann
D002460:Cell Line; D004252:DNA Mutational Analysis; D029043:Ebolavirus / Q000502:physiology*; D024202:Electrophoretic Mobility Shift Assay; D006801:Humans; D011485:Protein Binding; D012367:RNA, Viral / Q000378:metabolism*; D014157:Transcription Factors / Q000378:metabolism*; D014158:Transcription, Genetic; D014764:Viral Proteins / Q000378:metabolism*
D012367:RNA, Viral; D014157:Transcription Factors; C479897:VP30 protein, ebola virus; D014764:Viral Proteins